Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
289 studies found for:    Cerebral Atrophy
Show Display Options
Rank Status Study
21 Completed
Has Results
Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: Interferon beta 1b
22 Completed PET Imaging in Chronic Traumatic Encephalopathy
Conditions: Brain Disease;   Brain Mapping
Intervention:
23 Completed Does Glaucoma Cause Loss of Brain Function?
Condition: Glaucoma
Intervention:
24 Completed
Has Results
Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
Condition: Multiple Sclerosis, Chronic Progressive
Interventions: Drug: lipoic acid;   Drug: Placebo
25 Recruiting Telmisartan vs. Perindopril in Hypertensive Mild-Moderate Alzheimer's Disease Patients
Conditions: Alzheimer's Disease;   Hypertension
Interventions: Drug: Perindopril;   Drug: Telmisartan
26 Withdrawn Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: 95% Pure ECGC capsules 200mg;   Drug: Placebo Comparator:
27 Unknown  A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
28 Recruiting Cohort Study to Investigate the Association Between Changes in Brain Volume and Postoperative Cognitive Dysfunction
Conditions: Postoperative Cognitive Dysfunction;   Delirium;   Dementia
Intervention:
29 Terminated
Has Results
Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II
Condition: Multiple Sclerosis
Interventions: Drug: Polyphenon E;   Other: Placebo
30 Unknown  Automated Brain Morphometry for Dementia Diagnosis
Condition: Dementia
Interventions: Device: Brain Morphometry;   Other: Standard radiological assessment
31 Withdrawn Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life
Condition: Multiple Sclerosis
Intervention:
32 Recruiting DANish DELIrium Study On Neurointensive Care Patients
Conditions: Acquired Brain Injuries;   Delirium;   Acute Brain Injury
Intervention: Other: intervention bundle (sedation, pain, mobilization and sleep)
33 Recruiting The Microvascular Brain Retina And Kidney Study
Condition: Cerebral Small Vessels Disease
Intervention:
34 Recruiting Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD)
Conditions: Alzheimer Disease;   Benson's Disease
Intervention: Drug: [18F]T807 PET
35 Withdrawn Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment
Condition: Alzheimer's Disease
Interventions: Drug: CHF 5074 1x;   Drug: CHF 5074 2x;   Drug: Placebo
36 Unknown  Study of MRI 3Tesla Infusion Without Arterial Spin Labeling Injection (ASL) in Cognitive Atypical and Comparison to the FDG-PET
Condition: Atypical Cognitive Disorders
Intervention:
37 Completed Magnetic Stimulation Therapy for Treating Vascular Depression
Conditions: Depressive Disorder;   Depression
Interventions: Procedure: Repetitive transcranial magnetic stimulation (rTMS);   Drug: Citalopram;   Procedure: Sham rTMS
38 Not yet recruiting MRI Markers of Outcome After Severe Pediatric TBI
Condition: Brain Injuries
Intervention: Other: MRI Scans
39 Completed
Has Results
Progression Delaying Effect of Escitalopram in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: escitalopram;   Drug: placebo
40 Completed Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
Conditions: Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis
Interventions: Drug: natalizumab;   Other: standard of care

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.